mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.7 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.7 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.7 |